Dolomate

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dolomate

Property Description
Active Ingredient Ibuprofen (C13H18O2)
Form Tablet, Capsule, Oral Suspension, Suppository
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Purpose Analgesic, Antipyretic, Anti-inflammatory agent
Origin Synthetic, Small Molecule

Dolomate: Identity, Composition, and Pharmacological Class

Dolomate is a brand name preparation containing the active substance Ibuprofen, a synthetic small molecule classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Ibuprofen belongs to the chemical class of propionic acid derivatives. As a medicine with established therapeutic value, the product may be marketed as a single active ingredient product, containing only Ibuprofen, or potentially as a combination product that integrates another therapeutic agent, such as paracetamol.


How Dolomate Functions and Its General Therapeutic Purpose

The general therapeutic purpose of Dolomate is to provide relief from pain, reduce elevated body fever, and mitigate inflammation. It functions as a Cyclooxygenase (COX) inhibitor, temporarily blocking the production of prostaglandins—the chemical messengers that initiate these symptoms. This specific mechanism is clinically recognized for providing symptomatic relief across various general discomforts. Ibuprofen serves as both an analgesic and an anti-inflammatory compound, making the medicine useful for general pain relief and reducing swelling. The medicine's utility lies in its ability to interrupt the cycle of pain transmission, fever elevation, and inflammatory swelling at the chemical source, serving as a foundational symptomatic treatment.


What Forms of Dolomate are Available?

Dolomate is typically available in several common physical dosage forms associated with its active ingredient. These include solid oral preparations like the tablet and capsule, and liquid oral preparations such as the oral suspension or solution. The medicine may also be formulated for rectal administration as a suppository. This variety allows for flexible administration across patient groups, providing multiple routes of administration to suit different needs.

Regulatory References

  1. Model List of Essential Medicines

What side effects are possible with Dolomate?

Possible Side Effects and Safety Information

The safety profile of Dolomate, as documented in authoritative regulatory sources, primarily addresses risks associated with physical exposure to the material, focusing on hazards related to inhalation and direct contact.


Key Safety Domains

The officially documented risks are categorized by the systems they affect and the nature of the exposure.

Safety Domain Description of Risk
Chronic Inhalation Hazard Repeated or prolonged inhalation of respirable dust may cause damage to the lungs and respiratory system (Specific Target Organ Toxicity—Repeated Exposure). This includes the risk of developing a chronic lung disorder like silicosis.
Potential Carcinogenicity The product is classified as a potential human carcinogen (May cause cancer) due to the presence of trace amounts of respirable crystalline silica. This is a classification based on intrinsic hazard.
Acute Irritation Direct contact with the dust can cause acute irritation to the eyes, skin, and the lining of the respiratory and gastrointestinal tracts.

Safety-Related Restrictions and Considerations

The official safety information outlines specific restrictions and conditions for safe handling and use.

  • Exposure-Related Patterns: Serious adverse effects, such as cancer and chronic organ damage, are linked specifically to prolonged or repeated inhalation of the material’s dust. Acute irritation effects are linked to direct contact.
  • Mandatory Restrictions: Regulatory documents stipulate that safe use requires adherence to occupational exposure limits for airborne dust. Furthermore, the material used in sensitive applications (like food) is subject to strict trace impurity limits for heavy metals (including arsenic, lead, and cadmium) to manage potential systemic risks.
  • Population Note: Regulatory data suggests that pre-existing conditions affecting the eyes, skin, or lungs may be aggravated by exposure to the material.

This information reflects the intrinsic health hazards of the substance and its trace components as documented by government regulatory bodies, without providing instructions for use or clinical advice.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Dolomate (Ibuprofen) overdose outlines specific clinical manifestations and mandated emergency actions. Overconsumption may initially present with gastrointestinal symptoms such as nausea, vomiting, and abdominal pain, along with Central Nervous System disturbances, including drowsiness, severe headache, confusion, and ringing in the ears (tinnitus).


Severe Outcomes and Emergency Action

Regulatory documentation identifies the potential for severe or life-threatening outcomes. These serious manifestations include the development of metabolic acidosis, acute renal failure, and severe gastrointestinal bleeding or perforation. In profound cases, patients may experience convulsions (seizures) or loss of consciousness.

If an overdose is suspected, immediate medical attention must be sought or a Poison Control Center contacted right away. Urgent care is required when severe signs like difficulty breathing, severe hypotension, or signs of internal bleeding are present. Elderly patients are considered at a greater risk for serious gastrointestinal complications.

Management is strictly defined as symptomatic and supportive treatment, as no specific antidote is known for Ibuprofen overdose. Hospital monitoring, including continuous vital signs and laboratory parameters, is mandated to manage systemic toxicity.

Therapeutic Uses of Dolomate

What Dolomate Treats: Main Uses and Benefits

Dolomate, which contains Ibuprofen, is relevant across several key therapeutic domains. It is applied in contexts where additional symptomatic support is needed, providing support that may help ease the overall symptom burden. The medication is commonly used to help with symptoms related to physical discomfort, fever, and inflammatory states.

Therapeutic Scope and Applications

The medicine is commonly used in conditions characterized by periods of heightened symptoms, including musculoskeletal pain from strains or sprains, joint pain related to arthritis, various forms of headache, dental pain, and the general aches and pyrexia associated with the cold or flu. It is also commonly used to manage recurring localized discomfort, such as menstrual cramps (dysmenorrhea). Dolomate helps address symptom clusters that may become intense, primarily targeting the combination of pain, fever, and inflammation. This action provides supportive relief that helps patients cope more steadily with symptom fluctuations.


Quick Fact: Dolomate is relevant for managing Joint and Muscle Pain

Dolomate is often used when discomfort is driven by inflammation, contributing to the management of the symptomatic burden of conditions like Rheumatoid arthritis and easing stiffness and swelling in affected joints.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Dolomate? — Official Regulatory Information

Official regulatory documents from the U.S. Food and Drug Administration (FDA) classify the substance Dolomite (the mineral source of calcium magnesium carbonate) as Generally Recognized As Safe (GRAS) for a highly restricted purpose: to enhance the mineral content of purified bottled water. This GRAS status establishes strict boundaries for its commercial use, acting as the primary eligibility constraint.


Eligibility Scope

Classification Statement of Use (Regulatory Status)
Populations for whom use is allowed Intended for use solely as a substitute for GRAS calcium and magnesium salts in purified bottled water beverages to enhance taste and mineral content.
Age-related eligibility rules Not intended for use in infant formula. No other age-specific rules are officially documented for this use context.
Populations for whom use is contraindicated No formal drug contraindications are listed, as it is a food ingredient status.
Use is Restricted/Limited Not intended for products under the jurisdiction of the U.S. Department of Agriculture (USDA) or any use requiring additional regulatory review beyond GRAS status.

Regulatory Summary

The eligibility profile for Dolomite is defined by its food-grade regulatory context, not as an approved therapeutic drug. The classification of GRAS limits its use to the defined bottled water application and is the only official eligibility standard provided by regulatory bodies such as the FDA. The regulations explicitly exclude its use in certain commercial products and populations, establishing who cannot use the substance in that specific context. This framework dictates who can and cannot use the substance based on product type and consumer group, not on medical contraindications.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Dolomate's use must be carefully managed with other medicines and products due to potential changes in its concentration within the body or additive effects on certain systems.

Medicines Affecting Dolomate Levels

Co-administration with strong enzyme inhibitors, such as specific antifungal or antiviral medicines, can significantly increase the level of Dolomate in the body. Conversely, medicines classified as strong enzyme inducers, which include certain seizure medications or the herbal product St. John’s Wort, can substantially reduce Dolomate levels. Official labeling notes that a specific washout period of 14 days is required when transitioning from certain strong enzyme inducers before starting Dolomate. Additionally, some drugs that affect bodily transport systems, known as P-gp inhibitors, may also increase the amount of Dolomate absorbed.

Pharmacodynamic and Safety Interactions

Use of Dolomate is restricted with certain medicines that also affect the heart's electrical activity, specifically those that prolong the QTc interval, due to an increased risk of combined effects. Medicines that cause Central Nervous System (CNS) depression, such as pain relievers or sedatives, should be used with caution, as combined use may enhance these effects. Alcohol consumption is discouraged for this reason.

Mechanism of Action

Dolomate, a source of calcium-magnesium carbonate, undergoes chemical dissociation in the acidic environment of the upper gastrointestinal tract. This dissolution releases calcium ( Ca^2+) and magnesium ( Mg^2+) cations. The primary biological targets are systemic and cellular reservoirs requiring these divalent cations. Magnesium acts as an essential cofactor for over 300 enzyme systems, including those governing ATP hydrolysis and nucleic acid synthesis. System-level modulation by the absorbed magnesium involves it acting as a physiological calcium antagonist by binding to sites on the N-methyl-D-aspartate (NMDA) receptor channel, where it acts as a non-competitive inhibitor to regulate ion flow and neuronal excitability. Magnesium also influences the activity of voltage-gated calcium channels and potassium channels, modifying transmembrane ion flux. Consequently, these interactions modulate smooth muscle contractility and neuromuscular transmission, leading to systemic physiological consequences primarily involving cardiac and vascular tissue.

Dosage and Administration Information

The administration of Dolomate (Ibuprofen) typically involves using the lowest effective dose for the shortest duration necessary.

Administration Routes and Standard Dosing

Administration Route Typical Adult Dosing Maximum Daily Dose
Oral (Tablets, Capsules, Suspensions) 200 mg to 400 mg every 4 to 6 hours for acute symptoms. 3200 mg (Prescription-aligned) / 1200 mg (Non-prescription-aligned)
Intravenous (IV) (Solution for Infusion) 400 mg to 800 mg every 6 hours. 3200 mg

Use Conditions and Special Populations

Dosing Frequency and Duration

The interval between oral doses should be maintained at a minimum of 4 to 6 hours. For non-prescription use, the medicine should not be taken for more than 10 days for pain or 3 days for fever unless directed by a healthcare professional. For chronic use, the therapeutic response is often observed by two weeks.

Context of Intake

Oral forms of Dolomate may be administered with food or milk if the user experiences gastrointestinal discomfort, as this minimally alters the extent of absorption.

Population-Specific Rules

Dosage for older adults should be initiated at the lowest effective dose due to increased sensitivity to adverse effects. Pediatric oral dosing for children aged 6 months or older is generally based on body weight (mg/kg). The IV formulation must be administered by qualified healthcare professionals as an infusion over at least 30 minutes in an appropriate clinical environment.

Recent Clinical Evidence

Dolomate research relies extensively on Randomized Controlled Trials (RCTs) and systematic reviews to evaluate its clinical use. For acute, short-term physical discomfort, such as headache or post-operative pain, trials have examined outcomes related to patient-reported pain scores and the need for supplemental pain relievers (rescue medication). Research has described measurements indicating that increasing the dose beyond a certain point did not result in a proportionate change in measured outcomes, a pattern known as the analgesic ceiling.

In the context of fever, the research base has been evaluated through RCTs that primarily focused on pediatric patients (children). Studies examined outcomes linked to elevated body temperature by measuring the change in temperature from the starting point. Similarly, for chronic joint pain and inflammation (e.g., Osteoarthritis), studies monitored these conditions using specialized functional scales, such as the WOMAC Index, to document changes in physical functioning and perceived discomfort.

A key limitation across the research is the follow-up duration. Most efficacy trials for chronic conditions have relatively short intervention periods (weeks to a few months). Consequently, research exploring longer-term patterns of symptoms is scarce, and long-term effects are not fully established. For pediatric use, while the evidence base has been evaluated, the need for more rigorously designed, long-term studies focusing on the complete profile in children has been noted as a research gap.

Key Studies & References

  1. WHO Model List of Essential Medicines (23rd List) for Ibuprofen
  2. NICE Guideline [NG226]: Osteoarthritis in over 16s: diagnosis and management (Includes WOMAC context)

Frequently Asked Questions (FAQ)

Common questions about Dolomate (FAQ)

Q: Is Dolomate different from [Similar Drug Name]?

Dolomate is a brand name medicine containing the active ingredient Ibuprofen. According to official sources, this substance is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification distinguishes it from other types of pain relievers, such as acetaminophen, due to its specific way of working to reduce pain and inflammation.

Q: How quickly does Dolomate start working after taking it?

Official product information indicates that users may begin to notice symptom relief within 20 to 30 minutes after taking an oral dose. The maximum therapeutic effects are generally reached within one to two hours.

Q: Is it true that Dolomate can interact with cold and flu medicine?

Yes, interactions are possible because many nonprescription cold and flu products contain other pain-relieving ingredients, including other NSAIDs. The U.S. FDA warns patients against combining Ibuprofen with multiple pain relievers or cold medicines unless specifically guided by a healthcare professional.

Q: What happens if I miss a dose of Dolomate?

General regulatory guidance for this type of medication suggests that individuals should take their next scheduled dose at the usual time. Official information suggests avoiding taking extra medicine to make up for a dose that was missed.

Q: Is Dolomate considered a first-line treatment for its main use?

The active ingredient in Dolomate, Ibuprofen, is recognized globally as an established and foundational treatment for pain and fever. The World Health Organization (WHO) includes Ibuprofen on its Model List of Essential Medicines, confirming its established therapeutic value in global public health.

Q: Can I take Dolomate if I have existing kidney problems?

Official regulatory labeling for Ibuprofen advises patients who have existing kidney disease to consult with a healthcare professional before using the medicine. This precaution is noted because Ibuprofen is a drug that can potentially worsen the function of the kidneys.

Q: What are the major contraindications for Dolomate described in the official documents?

Major regulatory contraindications noted in official documents include having a history of allergic reactions to Ibuprofen or other NSAIDs. It is also contraindicated for use around the time of heart bypass surgery (CABG) and for people with severe heart or kidney disease.

Q: Is Dolomate appropriate for people with high blood pressure?

Patients who have high blood pressure (hypertension) are advised in regulatory warnings to consult a healthcare professional before use. This is because Ibuprofen is associated with the risk of fluid retention, which can potentially increase blood pressure.

Q: What should I do if a side effect seems mild but bothersome?

Regulatory information typically advises users to contact a healthcare professional if symptoms worsen, new symptoms appear, or if there are signs of any serious adverse events. The patient information also suggests consulting a professional for bothersome or persistent effects.

Q: Does Dolomate need to be tapered off, or can I stop taking it suddenly?

Unlike certain other drug classes, regulatory documents for Ibuprofen do not typically include a mandatory tapering schedule. The medicine can generally be stopped when it is no longer needed, in accordance with the prescribed or labeled duration of use.

Q: What patient groups are generally advised against using Dolomate?

Groups generally advised against using Ibuprofen include individuals with known allergic reactions to NSAIDs and those who have recently had heart bypass surgery (CABG). Regulatory data also advises caution or exclusion for individuals with severe heart failure or active severe stomach ulcers.

Q: Is Dolomate associated with weight gain or loss?

Official safety information indicates that Ibuprofen is associated with a risk of fluid retention (edema). This fluid retention can sometimes manifest as swelling in the hands, feet, or lower legs, and may contribute to a perceived or unusual weight gain.

Q: How is the safety of Dolomate evaluated in clinical trials?

Safety is evaluated using data from pre-market clinical trials and continuous post-marketing surveillance. This ongoing regulatory review of safety data, for instance, led the FDA to strengthen its public warning regarding the risk of serious events like heart attack and stroke associated with NSAID use.

Q: What is the purpose of the boxed warning, if one exists, for Dolomate?

The Boxed Warning (the strongest regulatory warning) is used to highlight the increased risk of two types of serious adverse events. These include potentially fatal cardiovascular thrombotic events, such as heart attack and stroke, and serious gastrointestinal events, including bleeding, ulceration, and perforation of the stomach or intestines.

Q: Does Dolomate interact with birth control pills?

Regulatory labels for Ibuprofen do not typically highlight a significant, well-established interaction with hormonal birth control pills. However, general guidance suggests the importance of consulting with a healthcare professional regarding all medicines and drugs being taken.

Q: What does 'use conditions' mean in the context of Dolomate's official labeling?

In official drug labeling, 'use conditions' refer to the specific rules and limitations for administering the medicine. These rules encompass details such as the minimum interval between doses, the maximum daily amount that can be taken, and the allowed duration of therapy.

Q: What is the risk of dependence or addiction with Dolomate?

Official information does not generally classify Ibuprofen as an addictive substance like opioids. However, regulatory documents caution against overuse and highlight the potential for psychological dependence, particularly if the medicine is taken in combination with or used to replace an opioid-based pain reliever.

Q: Do studies suggest Dolomate's effectiveness changes over time?

Studies do not typically indicate that the body builds up a pharmacological tolerance to Ibuprofen. This suggests that a person generally does not require increasingly larger doses over time to achieve the same effectiveness for the symptoms being treated.

Q: What are the non-promissory general expectations for someone starting Dolomate?

General expectations, according to official information, are relief from pain and a reduction of elevated body fever and inflammation. The onset of these therapeutic effects typically begins within the first half hour of taking the medicine.

Q: Is Dolomate primarily excreted by the kidneys or the liver?

Information on how the body handles the medicine indicates that the active ingredient is metabolized, or chemically processed, mainly by the liver. The drug and its byproducts are then primarily excreted from the body through the kidneys.

Q: Are there known food-drug interactions with Dolomate?

While taking the medicine with food or milk may slightly slow down how quickly it is absorbed, specific food types that are strictly forbidden are not commonly listed in regulatory labeling. It is noted that the medicine may be taken with food to help lessen any potential stomach upset.

Q: How long after stopping Dolomate can I safely consume alcohol?

While alcohol consumption is discouraged during use, traces of Ibuprofen may remain in the system for approximately 10 hours after the last dose, based on its half-life. Consult a healthcare professional if you have concerns regarding alcohol use post-treatment.

Q: Does Dolomate have a risk of allergic reactions?

Yes, the official product labeling includes an Allergy Alert warning. The medicine may cause a severe allergic reaction, which can manifest as hives, facial swelling, asthma (wheezing), or shock, especially in people who are already allergic to aspirin or other NSAIDs.

Q: What should I tell my dentist before a procedure if I am taking Dolomate?

Regulatory patient information advises that individuals should inform any healthcare professional, including their dentist, that they are taking Ibuprofen before undergoing any type of surgery or dental procedure.

Q: Is Dolomate effective for treating all forms of [Main Disease Category]?

Official information indicates that Ibuprofen is effective for specific types of pain, fever, and inflammation. However, it may not be appropriate or effective for all forms of a disease category, as some chronic inflammatory conditions may require weeks of consistent dosing to observe the full effect.

Q: What happens if I take more Dolomate than instructed?

Regulatory warnings emphasize that if more of the medicine is taken than instructed, the relevant authority advises seeking medical attention right away, often by contacting emergency medical services or a local poison control center.

Q: Can I use Dolomate if I am trying to become pregnant?

Official regulatory information advises that patients who are pregnant or planning to become pregnant should consult with a healthcare professional before using the medicine. Warnings specify that Ibuprofen may harm the fetus if taken at or after 20 weeks of pregnancy.

Q: Is it necessary to have regular blood tests while on Dolomate?

Regular blood tests are not typically required for short-term, over-the-counter use. However, for long-term or high-dose prescription use, regulatory guidance may recommend monitoring certain factors, such as blood pressure, kidney function, and signs of gastrointestinal bleeding.

Q: Are there any long-term research themes that are still being explored for Dolomate?

Research summaries note that one area of ongoing exploration is the scarcity of long-term data for chronic conditions. There is also a noted need for more rigorously designed, long-term studies to focus on the complete safety and efficacy profile in pediatric patients.

Q: What are the initial signs that Dolomate may be working?

The initial signs that the medicine may be working are the subjective relief of the symptoms being treated. This includes a reduction in the severity of pain or the lowering of an elevated body temperature, which often begins shortly after dosing.

Q: What kind of side effects are common with Dolomate?

Official patient information lists common side effects, primarily involving the gastrointestinal system, such as stomach pain, nausea, and heartburn. Central Nervous System effects, like headache and dizziness, are also frequently reported.

Q: Do I need to avoid any specific types of food while taking Dolomate?

Regulatory documents do not typically list specific food types that are strictly forbidden when taking the medicine. However, it is noted that taking the medicine with food or milk may help lessen the occurrence of stomach upset.

Q: Are there any long-term effects associated with using Dolomate?

Official warnings highlight the serious long-term effects associated with use, particularly with high-dose or chronic therapy. These risks include an increased potential for cardiovascular events, such as heart attack and stroke, and serious gastrointestinal complications, like internal bleeding and ulceration.

Q: What are the most common side effects mentioned in patient reports?

The most frequently reported effects from patient data often involve the digestive tract, such as stomach pain, heartburn, and nausea. Central nervous system effects like headache and dizziness are also commonly reported in official documents.

Q: Is Dolomate known to cause drowsiness or fatigue?

Drowsiness and fatigue are listed as known, though less common, side effects of the medicine. Official warnings advise that the risk of central nervous system effects is increased if the medicine is taken along with other central nervous system depressants.

Q: Is there a generic version of Dolomate available?

Dolomate is a specific brand name preparation. The active ingredient it contains is Ibuprofen, which is widely available as an official generic medicine.

Q: Can I take Dolomate if I am currently taking herbal supplements?

Official guidance advises patients to consult with a healthcare professional before combining the medicine with any herbal supplements. This precaution is noted because some supplements have the potential to interact and affect the drug's levels in the body.

Q: Is it normal to feel nauseous when starting Dolomate?

Yes, nausea is listed as a common side effect in the official product information. This effect is particularly noted when the medicine is taken on an empty stomach, which is why it may be taken with food or milk.

Q: What are the key points about Dolomate's safety classification?

The official safety classification is defined by the medicine's status as an NSAID. This carries two major regulatory warnings regarding the risk of serious cardiovascular events, such as heart attack and stroke, and serious gastrointestinal events, including bleeding and ulceration.

Q: Are there restrictions on driving or operating machinery while taking Dolomate?

Regulatory warnings state that driving or operating machinery is restricted if an individual experiences certain side effects, such as dizziness, lightheadedness, or drowsiness, while taking the medication.

How should Dolomate be stored and disposed of?

Storage and Disposal Instructions

Official regulatory documents define specific storage and disposal requirements for Dolomate (Ibuprofen) to maintain its quality.


Storage Conditions

Temperature and Environment: Store the medication at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and excessive heat.

Handling and Packaging: Keep the medicine in its original container and ensure the container remains tightly closed. The oral suspension form must not be frozen.

Child Safety: Dolomate must be stored out of the sight and reach of children at all times.


Disposal Rules

Unused Medicine: Dispose of unused or expired Dolomate through an authorized drug take-back program. Do not flush the medication down the toilet or pour it into a drain unless explicitly instructed by the product label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolomate found in:

A-Z Index: